Tue, April 12, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Tracy Benguigui Maintained (TRV) at Hold with Increased Target to $185 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Elyse Greenspan Maintained (TRV) at Hold with Increased Target to $180 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
William Katz Maintained (TROW) at Strong Sell with Decreased Target to $110 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Magnus Fyhr Initiated (TRMD) at Strong Buy and Held Target at $14 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
William Katz Maintained (TPG) at Hold with Decreased Target to $27 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
David Long Upgraded (THFF) to Buy and Held Target at $49 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Rudy Kessinger Initiated (TENB) at Strong Buy and Held Target at $75 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
David Kelley Maintained (TEL) at Strong Buy and Held Target at $160 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Samik Chatterjee Maintained (TEL) at Buy and Held Target at $166 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Sean Dodge Maintained (TDOC) at Buy with Decreased Target to $120 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Susan Maklari Maintained (SWIM) at Hold with Decreased Target to $15 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Frank Louthan Maintained (T) at Buy with Decreased Target to $26 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Michael Rollins Maintained (T) at Strong Buy with Decreased Target to $22 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
John Vinh Maintained (SYNA) at Buy with Decreased Target to $250 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Craig Ellis Downgraded (SWKS) to Hold and Decreased Target to $138 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
John Vinh Maintained (SWKS) at Buy with Decreased Target to $175 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Neil Kalton Maintained (CEG) at Buy with Increased Target to $75 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Jason Celino Downgraded (CHGG) to Hold on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Jason McCarthy Initiated (SNPX) at Strong Buy and Held Target at $350 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Matthew Harrison Maintained (SRPT) at Hold with Decreased Target to $77 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Keagan Bryce-Borthwick Downgraded (STM) to Hold on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Scott Graham Initiated (XMTR) at Strong Buy and Held Target at $50 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Jon Tower Initiated (YUM) at Strong Buy and Held Target at $156 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Jon Tower Initiated (TXRH) at Strong Buy and Held Target at $105 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Shebly Seyrafi Initiated (UPST) at Buy and Held Target at $150 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Tracy Benguigui Maintained (UNM) at Sell with Increased Target to $31 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Quinn Bolton Maintained (UCTT) at Strong Buy with Decreased Target to $53 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Patrick Ho Maintained (WDC) at Strong Buy with Increased Target to $85 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Samuel Eisner Maintained (WHR) at Strong Buy with Decreased Target to $220 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Jeffrey Silber Downgraded (WM) to Hold and Held Target at $174 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Jon Tower Initiated (WING) at Strong Buy and Held Target at $160 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Elyse Greenspan Maintained (WRB) at Buy with Increased Target to $51 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Karl Keirstead Initiated (VERI) at Hold and Held Target at $18 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Leland Gershell Maintained (VERU) at Buy with Increased Target to $36 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Yi Chen Maintained (VERU) at Strong Buy with Increased Target to $24 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Robert Moskow Downgraded (UTZ) to Hold and Decreased Target to $17 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Brian Essex Downgraded (VRNT) to Hold on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Saket Kalia Maintained (VRNS) at Hold with Increased Target to $51 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Jon Tower Initiated (BJRI) at Hold and Held Target at $29 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
William Katz Maintained (BLK) at Strong Buy with Increased Target to $900 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Jon Tower Initiated (BLMN) at Hold and Held Target at $24 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Matthew Harrison Maintained (BMRN) at Hold with Increased Target to $96 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Patrick Walravens Maintained (BRZE) at Buy with Decreased Target to $75 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
William Katz Maintained (BRDG) at Strong Buy with Decreased Target to $24 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Robert Burns Maintained (BNTX) at Strong Buy with Decreased Target to $298 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Matthew Harrison Maintained (BNTX) at Hold with Decreased Target to $197 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
Steven Cahall Maintained (BOC) at Buy with Decreased Target to $33 on, Apr 12th, 2022
[ Tue, Apr 12th 2022 ]: WOPRAI
William Katz Maintained (BX) at Hold with Decreased Target to $117 on, Apr 12th, 2022

Brian Abrahams Maintained (BCRX) at Hold with Decreased Target to $14 on, Apr 12th, 2022

Brian Abrahams of RBC Capital, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Hold with Decreased Target from $16 to $14 on, Apr 12th, 2022.

Brian has made no other calls on BCRX in the last 4 months.



There are 2 other peers that have a rating on BCRX. Out of the 2 peers that are also analyzing BCRX, 1 agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold and Held Target at $14 on, Monday, April 11th, 2022


This is the rating of the analyst that currently disagrees with Brian

  • Justin Kim of "Oppenheimer" Maintained at Buy with Decreased Target to $16 on, Monday, April 11th, 2022